Drugs Made In America Acquisition DMAAU
NASDAQ DMAAU
$10.79 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition Corp. (DMAAU) Other financing activities (2025)

Drugs Made In America Acquisition's (DMAAU) quarterly Other financing activities came in at $3.2 million in Q1 2025.

Drugs Made In America Acquisition Corp. (DMAAU) Other financing activities (2025) Analysis & Trends

Drugs Made In America Acquisition (DMAAU) has 1 years of Other financing activities data on file, last reported at $3.2 million in Q1 2025.

  • Quarterly Other financing activities changed N/A year-over-year to $3.2 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $3.2 million (changed N/A YoY) and the FY2025 annual result came in at $3.2 million, changed N/A from the prior year.
  • Other financing activities held at $3.2 million in Q1 2025.
  • In the past five years, Other financing activities ranged from a high of $3.2 million in Q1 2025 to a low of $3.2 million in Q1 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2025 3.20 Mn
Mar 31, 2025 3.20 Mn